US FDA's On-Time Review Decision Rates Slip During The Pandemic, Especially For Biosimilars

 
• By Derrick Gingery
Dam leaking
Is the dam starting to crack in the US FDA's pandemic review performance? • Source: Shutterstock

More from Product Reviews

More from Pink Sheet